## Core Concept
Statins are a group of cholesterol-lowering medications that work by inhibiting a key enzyme in the biosynthesis of cholesterol. The primary site of action of statins is in the liver, where they exert their effect on cholesterol production. The enzyme targeted by statins is crucial for the conversion of certain precursors into cholesterol.

## Why the Correct Answer is Right
The correct answer, **HMG-CoA reductase**, is the enzyme responsible for converting 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) into mevalonate, a necessary step in the hepatic production of cholesterol. Statins structurally mimic HMG-CoA and competitively inhibit HMG-CoA reductase, thereby reducing the liver's ability to produce cholesterol. This reduction in cholesterol synthesis leads to an increase in the expression of low-density lipoprotein (LDL) receptors on the surface of liver cells, which in turn increases the clearance of LDL cholesterol from the bloodstream.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately represent the enzyme targeted by statins.
- **Option B:** This option is incorrect as it also does not correctly identify the enzyme inhibited by statins.
- **Option C:** This option is incorrect because, although it might seem related, it is not the specific enzyme on which statins act.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the effectiveness of statins in lowering LDL cholesterol levels is due to their ability to inhibit **HMG-CoA reductase**. This action not only reduces cholesterol synthesis in the liver but also has pleiotropic effects, including improving endothelial function and reducing inflammation. Statins are among the most commonly prescribed drugs for the prevention and treatment of cardiovascular disease.

## Correct Answer: D. HMG-CoA reductase.